Special notice
NCI OA Special Notice of Subcontract Opportunity at the Frederick National Laboratory for Cancer Research”
National Institutes of Health, NIH NCI.
Response deadline
November 20, 2026 at 3:00 PM EST
Closed in 19 days. Posted October 20, 2026. Scheduled to archive December 5, 2026.
Get the next one like this from National Institutes of Health by email, the day it is posted.Find my opportunities
Description
As published on SAM.gov.
SOLCITATION H27-1001
Description of Work: Frederick National Laboratory for Cancer Research (FNLCR) Operated by Leidos Biomedical Research, Inc. (Leidos Biomed) for the National Cancer Institute requires an Indefinite Delivery/Indefinite Quantity Subcontract for construction services for the Frederick National Laboratory for Cancer Research (FNLCR).
To obtain a copy of solicitation H27-1001 and other information concerning this opportunity, please refer to:
https://frederick.cancer.gov/work-us/vendors-subcontractors/business-opportunities/construction-idiq-contract
or
contact Matthew Hull (Contracts Manager) at matthew.hull@nih.gov
For information concerning other opportunities with the FNLCR, please refer to: https://frederick.cancer.gov/workwithus/solicitations
Background Information: Leidos Biomedical Research, Inc. (Leidos Biomed), a subsidiary of Leidos Corporation, a Delaware corporation with offices in Frederick, MD is the Operations and Technical Support (OTS) contractor for the National Cancer Institute at Frederick. The effort to be performed will be part of Leidos Biomed’s Prime Contract 75N91019D00024 that has been issued by the National Cancer Institute, National Institutes of Health, Frederick, MD.
The FNLCR is a Government-Owned Contractor-Operated Federally Funded Research and Development Center (FFRDC) located at Fort Detrick, Maryland. The FNLCR partners with university, Government, and corporate scientists to speed the translation of laboratory research into new diagnostic tests and treatments for cancer and AIDS. FNLCR is a multi-program laboratory currently operated by Leidos Biomedical Research, Inc. (Leidos Biomed) for the National Cancer Institute (NCI) under Prime Contract No. 75N91019D00024 & HHSN261201500003I, which provides Operations and Technical Support (OTS) for the FNLCR.
The Government assumes no liability for reimbursement for any effort or associated costs to respond, nor for any information provided as a result of this Special Notice as no information is being requested. Please be advised that any submissions provided, despite that no information is requested, become Government property and will not be returned, nor will there be any ensuing discussions or debriefings.
Responses submitted to this Special Notice are not offers and cannot be accepted by the U.S. Government to form a binding contract. It is the responsibility of the interested parties to monitor this site and any sites referenced herein for additional information pertaining to business opportunities with the FNLCR, if any.
Attachments
Files listed on SAM.gov. The ones we hold a copy of download from here; the rest open SAM's download, which needs no account.
- SAM Request (Amend 01 - H27-1001).pdf220 KB, October 20, 2026
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
October 20, 2026
Special notice
Due November 20, 2026 at 3:00 PM EST. SAM.gov, notice 549d9c266b1a435b887f5676c2dbd82d
1 revisions on SAM
- October 20, 2026: publish, special notice
Points of contact
- Matthew Hullmatthew.hull@nih.gov